{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:46:46Z","timestamp":1772894806845,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1124\/mol.106.023150","type":"journal-article","created":{"date-parts":[[2006,5,11]],"date-time":"2006-05-11T04:51:16Z","timestamp":1147323076000},"page":"697-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Validation of the Anti-Inflammatory Properties of Small-Molecule I\u03baB Kinase (IKK)-2 Inhibitors by Comparison with Adenoviral-Mediated Delivery of Dominant-Negative IKK1 and IKK2 in Human Airways Smooth Muscle"],"prefix":"10.1016","volume":"70","author":[{"given":"Matthew C.","family":"Catley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria B.","family":"Sukkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. Fan","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Jaffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha-Mei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Coyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El-Bdaoui","family":"Haddad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/mol.106.023150_REF1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.coph.2004.02.001","article-title":"Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?","volume":"4","author":"Adcock","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/mol.106.023150_REF2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ccr.2004.09.003","article-title":"Nuclear factor-kappaB: the enemy within","volume":"6","author":"Aggarwal","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1124\/mol.106.023150_REF3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1165\/ajrcmb.26.4.4681","article-title":"Tumor necrosis factor-alpha-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists","volume":"26","author":"Ammit","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/mol.106.023150_REF4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrd1524","article-title":"New drugs for asthma","volume":"3","author":"Barnes","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.106.023150_REF5","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(04)17025-6","article-title":"Prospects for new drugs for chronic obstructive pulmonary disease","volume":"364","author":"Barnes","year":"2004","journal-title":"Lancet"},{"key":"10.1124\/mol.106.023150_REF6","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1056\/NEJM199704103361506","article-title":"Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases","volume":"336","author":"Barnes","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.106.023150_REF7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/sj.bjp.0700963","article-title":"Induction of cyclo-oxygenase-2 by cytokines in human cultured airway smooth muscle cells: novel inflammatory role of this cell type","volume":"120","author":"Belvisi","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.023150_REF8","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1016\/S0960-894X(03)00408-6","article-title":"Novel IKK inhibitors: beta-carbolines","volume":"13","author":"Castro","year":"2003","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1124\/mol.106.023150_REF9","doi-asserted-by":"crossref","first-page":"18457","DOI":"10.1074\/jbc.M400765200","article-title":"Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-\u03baB DNA binding","volume":"279","author":"Catley","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.023150_REF10","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(03)00672-0","article-title":"IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase","volume":"547","author":"Catley","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.106.023150_REF11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.bjp.0706170","article-title":"Validation of IKK beta as therapeutic target in airway inflammatory disease by adenoviral-mediated delivery of dominant-negative IKK beta to pulmonary epithelial cells","volume":"145","author":"Catley","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.023150_REF12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/sj.bjp.0705716","article-title":"Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF","volume":"141","author":"Clarke","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.023150_REF13","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/9550","article-title":"Inducible cyclooxygenase may have anti-inflammatory properties","volume":"5","author":"Gilroy","year":"1999","journal-title":"Nat Med"},{"key":"10.1124\/mol.106.023150_REF14","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1101\/gad.1228704","article-title":"Signaling to NF-kappaB","volume":"18","author":"Hayden","year":"2004","journal-title":"Genes Dev"},{"key":"10.1124\/mol.106.023150_REF15","doi-asserted-by":"crossref","first-page":"16639","DOI":"10.1074\/jbc.M200360200","article-title":"NF-\u03baB as a therapeutic target in multiple myeloma","volume":"277","author":"Hideshima","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.023150_REF16","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/j.1432-1033.2004.03982.x","article-title":"ICAM-1 expression is highly NF-kappaB-dependent in A549 cells. No role for ERK and P38 MAPK","volume":"271","author":"Holden","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1124\/mol.106.023150_REF17","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jaci.2004.04.041","article-title":"Synthetic responses in airway smooth muscle","volume":"114","author":"Howarth","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1124\/mol.106.023150_REF18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1046\/j.0014-2972.2001.00954.x","article-title":"A new insight into aspirin-induced asthma","volume":"32","author":"Jawien","year":"2002","journal-title":"Eur J Clin Investig"},{"key":"10.1124\/mol.106.023150_REF19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrd1279","article-title":"The IKK NF-kappaB system: a treasure trove for drug development","volume":"3","author":"Karin","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.106.023150_REF20","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1002\/j.1460-2075.1996.tb01061.x","article-title":"Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor Ikap-paB alpha in vivo","volume":"15","author":"Krappmann","year":"1996","journal-title":"EMBO (Eur Mol Biol Organ) J"},{"key":"10.1124\/mol.106.023150_REF21","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nature03491","article-title":"IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation","volume":"434","author":"Lawrence","year":"2005","journal-title":"Nature (Lond)"},{"key":"10.1124\/mol.106.023150_REF22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0014-2999(01)01520-5","article-title":"RANTES release by human airway smooth muscle: effects of prostaglandin E2 and fenoterol","volume":"433","author":"Lazzeri","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.106.023150_REF23","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF-KappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1124\/mol.106.023150_REF24","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood-2005-09-3852","article-title":"Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKK\u03b2","volume":"107","author":"Nagashima","year":"2006","journal-title":"Blood"},{"key":"10.1124\/mol.106.023150_REF25","doi-asserted-by":"crossref","first-page":"19965","DOI":"10.1074\/jbc.274.28.19965","article-title":"Differential I\u03baB kinase activation and I\u03baB\u03b1 degradation by interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in human U937 monocytic cells. Evidence for additional regulatory steps in \u03baB-dependent transcription","volume":"274","author":"Nasuhara","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.106.023150_REF26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/bbrc.2001.5569","article-title":"GM-CSF expression in pulmonary epithelial cells is regulated negatively by posttranscriptional mechanisms","volume":"287","author":"Newton","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/mol.106.023150_REF27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(97)01362-8","article-title":"Superinduction of COX-2 MRNA by cycloheximide and interleukin-1beta involves increased transcription and correlates with increased NF-kappaB and JNK activation","volume":"418","author":"Newton","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.106.023150_REF28","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1124\/mol.106.023150_REF29","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bjp.0701152","article-title":"Effect of interleukin-1 beta, tumour necrosis factor-alpha and interferon-gamma on the induction of cyclo-oxygenase-2 in cultured human airway smooth muscle cells","volume":"121","author":"Pang","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.106.023150_REF30","first-page":"L1230","article-title":"Fractalkine\/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids","volume":"287","author":"Sukkar","year":"2004","journal-title":"Am J Physiol"},{"key":"10.1124\/mol.106.023150_REF31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/thorax.57.7.590","article-title":"Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD","volume":"57","author":"Traves","year":"2002","journal-title":"Thorax"},{"key":"10.1124\/mol.106.023150_REF32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1189\/jlb.1003495","article-title":"Specific CXC but not CC chemokines cause elevated monocyte migration in COPD: a role for CXCR2","volume":"76","author":"Traves","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1124\/mol.106.023150_REF33","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.105.097584","article-title":"A selective small molecule IKK\u03b2 inhibitor blocks NF-\u03baB mediated inflammatory responses in human fibroblast like synoviocytes, chondrocytes and mast cells","volume":"317","author":"Wen","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.106.023150_REF34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0140-6736(04)16984-5","article-title":"Management of severe COPD","volume":"364","author":"Wouters","year":"2004","journal-title":"Lancet"},{"key":"10.1124\/mol.106.023150_REF35","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0092-8674(00)80406-7","article-title":"The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-KappaB activation","volume":"91","author":"Zandi","year":"1997","journal-title":"Cell"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24041087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24041087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.106.023150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T11:31:59Z","timestamp":1739964719000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24041087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0026895X24041087"],"URL":"https:\/\/doi.org\/10.1124\/mol.106.023150","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the Anti-Inflammatory Properties of Small-Molecule I\u03baB Kinase (IKK)-2 Inhibitors by Comparison with Adenoviral-Mediated Delivery of Dominant-Negative IKK1 and IKK2 in Human Airways Smooth Muscle","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.106.023150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}